Andreatta M. and Nielsen M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 2016; 32:511-7.
Bergmann-Leitner ES, Mease RM, De La Vega P, Savranskaya T, Polhemus M, Ockenhouse C, Angov E. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium. falciparum elicits cross-species protection against heterologous challenge with P. berghei. PloS one. 2010; 5(8): e12294.
Buus S, Lauemøller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003; 62:378-384.
Cech PG, Aebi T, Abdallah MS, Mpina M, Machunda EB, Westerfeld N, Stoffel SA, Zurbriggen R, Pluschke G, Tanner M, Daubenberger C, Genton B, Abdulla S. Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. PLoS ONE. 2011; 6: e22273.
Dinga JN, Dobgima GS, Titanji VPK. Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05-09 is associated with protective immunity against malaria. Parasite Immunol. 2017; 39:e12445.
Dinga JN, Gamua SD, Ghogomu SM, Titanji VPK. Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a malaria vaccine candidate. Parasite Immunol. 2018; e12514.
Dinga JN, Mbandi SK, Cho-Ngwa F, Nde PF, Moliki J, Efeti RM, Nyasa BR, Anong DN, Jojic N, Heckerman D, Wang R, Titanji VPK. Differential T-cell responses of semi-immune and susceptible malaria subjects to in silico predicted and synthetic peptides of Plasmodium falciparum. Act Trop 2014; 135: 104–121.
Dinga JN, Njimoh DL, Kiawa B, Djikeng A, Nyasa RB, Nkuo-Akenji T, Pelle R, Titanji VPK. Differential T-cell responses to a chimeric Plasmodium falciparum antigen; UB05-09, correlates with acquired immunity to malaria. Parasite Immunol. 2016; 38:303‐316.
Dinga JN, Wamalwa M, Njimoh DL, Njahira MNN, Djikeng A, Skilton R, Titanji VPK, Pelle R. TpUB05, a homologue of the immunodominant Plasmodium falciparum protein UB05, is a marker of protective immune responses in cattle experimentally vaccinated against east coast fever. PLoS ONE. 2015; 10: e0128040.
Doolan DL and Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Current Molecular Medicine, 2006; 6:169–185.
Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009; 22:13‐36.
Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985; 55:836-9.
Fine PEM, Cameiro IAM, Milstein JB, Clements CJ, World Health Organization. Issues relating to the use of BCG in immunization programs: a discussion document. World Health Organization. https://apps.who.int/iris/handle/10665/66120. Accessed 15 Aug 2019.
Gabaldón T and Koonin VE. Functional and evolutionary implications of gene orthology. Nat Rev Genet. 2013; 14(5): 360 – 366.
Gowda DC and Wu X. 2018. Parasite Recognition and Signaling Mechanisms, innate immune responses to malaria. Front. Immunol, 2018; 9:3006. doi: 10.3389/fimmu.2018.03006.
Greenhouse B, uthor1 Benjamin Ho,corresponding author3 Alan Hubbard, Njama-Meya D, Narum DL, Lanar DE, Dutta S, Rosenthal PJ, Dorsey G, John CC. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis. 2011; 204:19‐26.
Siciliano G, Alano P. Enlightening the malaria parasite life cycle: bioluminescent Plsmodium in fundamental and applied research. Front Microbiol. 2015;6:391. doi:10.3389/fmicb.2015.00391.
Hogh B. “Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children,” Scand J Infect Dis Suppl. 1996;102:1–53.
Jansky L, Reymanova P, Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res. 2003;52:593–598.
Jens Erik Pontoppidan Larsen, Ole Lund and Morten Nielsen. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006; 2: 2.
Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res 2017.
Jiang G, Charoenvit Y, Moreno A, Baraceros MF, Banania G, Richie N, Abot S, Ganeshan H, Fallarme V, Patterson NB, Geall A, Weiss WR, Strobert E, Caro-Aquilar I, Lanar DE, Saul A, Martin LB, Gowda K, Morrissette CR, Kaslow DC, Carucci DJ, Galinski MR, Doolan DL. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J 2007; 6: 135.
Katende J, Morzaria S, Toye P, Skilton R, Nene V, Nkonge C, Musoke A. An enzyme-linked Immunosorbent assay for detection of Theileria parva antibodies in cattle using a recombinant polymorphic immunodominant molecule. Parasitol Res. 1998; 84:408‐416.
Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990; 276:172-4.
Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, and Nielsen M. NetMHC-3.0: Accurate web accessible predictions of Human, Mouse, and Monkey MHC class I affinities for peptides of length 8-11. NAR 2008; 36:509-512.
Miura K. Progress and prospects for blood-stage malaria vaccines. Expert Rev Vaccines. 2016; 15:765‐781.
Lundegaard C, Nielsen M, Lund O. The validity of predicted T-cell epitopes. Trends Biotechnol 2006; 24:537-538.
Lundegaard C, Lund O, and Nielsen M. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 2008; 24:1397-1398.
Moll K, Kaneko A, Scherf A, Wahlgren M. Methods in Malaria Research, 6th edn. Glasgow: EVIMalaR; 2013.
Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K, Buus S, Brunak S, Lund O. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003; 12:1007-1017.
Nkuo Akenji TK, Ntonifor NN, Ching JK, Kimbi HK, Ndamukong NK, Anong DN, Boyo MG, Titanji VPK. Evaluating a malaria intervention strategy using knowledge, practices and coverage surveys in rural Bolifamba, southwest Cameroon. Trans R Soc Trop Med Hyg. 2005; 99: 325‐332.
Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno, L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR. Blood stage malaria vaccine eliciting high antigenspecific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 2009; 4: e4708.
Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, Lievens M, Leboulleux D, Njuguna P, Peshu N, Marsh K, Bejon P. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med 2013; 368:1111–1120.
Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005; 6:132
Pinder M, Reece WHH, Plebanski M, Akinwunmi P, Flanagan KL, Lee EAM, Doherty T, Milligan P, Jaye A, Tornieporth N, Ballous R, Mcadam KPMJ, Cohen J, Hill AVS. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS, S/AS02, in semi-immune adults in The Gambia. Clin Exp Immunol 2004; 135: 286–293.
Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C & Avery AJ. The relationship between body mass index and healthrelated quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Int J Obes (Lond) 2007; 31: 189–196.
Shanehsazzadeh S, Oghabian MA, Allen BJ, Amanlou M, Masoudi A & Daha FJ. Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long term magnetic cell labeling. J Med Phys 2013; 38: 34–40.
Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 2008; 4:2.
Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, Angov E, Bergmann-Leitner E, Stewart VA, Bittner S, Juompan L, Kortepeter MG, Nielsen R, Krzych U, Tierney E, Ware LA, Dowler M, Hermsen CC, Sauerwein RW, de Vlas SJ, Ofori-Anyinam O, Lanar DE, Williams JL, Kester KE, Tucker K, Shi M, Malkin E, Long C, Diggs CL, Soisson L, Dubois MC, Ballou WR, Cohen J, Heppner DG, Jr. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS ONE 2009; 4, e5254.
Suhrcke M, Stuckler D, Suk JE, Desai M, Senek M, McKee M, Tsolova S, Basu S, Abubakar I, Hunter P, Rechel B, Semenza JC. The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One 2011; 6: e20724. doi:10.1371/journal.pone.0020724
Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming “vaccine resistant malaria”. Parasite Immunol. 2009; 31:560‐573.
Titanji VP, Amambua-Ngwa A, Anong DN, Mbandi SK, Tangie E, Tening I, Yengo R. Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the cameroonian rainforest. Clin Chem Lab Med. 2009;47:1147‐58. doi:10.1515/CCLM.2009.255.
Titanji VPK, Dinga JN, Nyasa RB. A rational approach for predicting the minimum composition of anti-parasite sub-unit vaccines: A multiple target vaccine hypothesis. Journal of the Cameroon Academy of Sciences. 2017; 14:3-10.
Wahl G, Enyong P, Ngosso A, Schibel JM, Moyou R, Tubbessing H, et al. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man. Parasitology 1998; 116: 349 – 362.
Wang P, Sidney J, Dow C, Mothé B, Sette A, Peters B. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol. 2008; 4:e1000048.
Yadava A, Nurmukhambetova S, Pichugin AV, Lumsden JM. Cross-Species Immunity Following Immunization With a Circumsporozoite Protein–Based Vaccine for Malaria. Journal of Infectious Diseases. 2012; 205:1456–63.